- Home
- ELSE vs TNXP Comparison
ELSE vs TNXP Comparison
Compare ELSE & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- TNXP
- Stock Information
- Founded
- ELSE 1968
- TNXP 2007
- Country
- ELSE United States
- TNXP United States
- Employees
- ELSE N/A
- TNXP N/A
- Industry
- ELSE Industrial Machinery/Components
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- TNXP Health Care
- Exchange
- ELSE Nasdaq
- TNXP Nasdaq
- Market Cap
- ELSE 13.2M
- TNXP 15.1M
- IPO Year
- ELSE N/A
- TNXP N/A
- Fundamental
- Price
- ELSE $3.90
- TNXP $0.14
- Analyst Decision
- ELSE
- TNXP Strong Buy
- Analyst Count
- ELSE 0
- TNXP 2
- Target Price
- ELSE N/A
- TNXP $53.50
- AVG Volume (30 Days)
- ELSE 2.2K
- TNXP 35.9M
- Earning Date
- ELSE 11-12-2024
- TNXP 11-07-2024
- Dividend Yield
- ELSE N/A
- TNXP N/A
- EPS Growth
- ELSE N/A
- TNXP N/A
- EPS
- ELSE 0.06
- TNXP N/A
- Revenue
- ELSE $8,834,000.00
- TNXP $12,458,000.00
- Revenue This Year
- ELSE N/A
- TNXP $62.53
- Revenue Next Year
- ELSE N/A
- TNXP $26.17
- P/E Ratio
- ELSE $63.66
- TNXP N/A
- Revenue Growth
- ELSE 3.78
- TNXP N/A
- 52 Week Low
- ELSE $3.65
- TNXP $0.12
- 52 Week High
- ELSE $4.40
- TNXP $22.08
- Technical
- Relative Strength Index (RSI)
- ELSE 46.18
- TNXP 29.54
- Support Level
- ELSE $3.91
- TNXP $0.12
- Resistance Level
- ELSE $4.05
- TNXP $0.21
- Average True Range (ATR)
- ELSE 0.03
- TNXP 0.02
- MACD
- ELSE -0.01
- TNXP 0.02
- Stochastic Oscillator
- ELSE 0.00
- TNXP 21.56
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.